1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-22.13%
Negative revenue growth while MAXN stands at 25.22%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
71.96%
Positive gross profit growth while MAXN is negative. John Neff would see a clear operational edge over the competitor.
139.53%
Positive EBIT growth while MAXN is negative. John Neff might see a substantial edge in operational management.
71.69%
Positive operating income growth while MAXN is negative. John Neff might view this as a competitive edge in operations.
130.29%
Positive net income growth while MAXN is negative. John Neff might see a big relative performance advantage.
116.67%
Positive EPS growth while MAXN is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
100.00%
Positive diluted EPS growth while MAXN is negative. John Neff might view this as a strong relative advantage in controlling dilution.
0.06%
Share reduction more than 1.5x MAXN's 16.31%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
3.38%
Diluted share reduction more than 1.5x MAXN's 16.49%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-311.47%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-447.93%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
-71.88%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-42.02%
Both face negative 5Y revenue/share CAGR. Martin Whitman would suspect macro headwinds or obsolete product offerings across the niche.
-53.61%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
14.81%
Positive long-term OCF/share growth while MAXN is negative. John Neff would see a structural advantage in sustained cash generation.
66.29%
Positive OCF/share growth while MAXN is negative. John Neff might see a comparative advantage in operational cash viability.
-34.59%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
24.98%
Positive 10Y CAGR while MAXN is negative. John Neff might see a substantial advantage in bottom-line trajectory.
163.56%
Positive 5Y CAGR while MAXN is negative. John Neff might view this as a strong mid-term relative advantage.
167.47%
Positive short-term CAGR while MAXN is negative. John Neff would see a clear advantage in near-term profit trajectory.
-100.41%
Negative equity/share CAGR over 10 years while MAXN stands at 0.00%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-100.54%
Negative 5Y equity/share growth while MAXN is at 0.00%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-101.20%
Negative 3Y equity/share growth while MAXN is at 0.00%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-11.54%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-50.57%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-25.24%
Negative asset growth while MAXN invests at 38.32%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-117.10%
We have a declining book value while MAXN shows 35.28%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-7.17%
We’re deleveraging while MAXN stands at 174.53%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-56.68%
Our R&D shrinks while MAXN invests at 39.45%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-36.64%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.